Pfizer chief Albert Bourla wins $1 mn Genesis Prize for vaccine development
Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine
Pune-based Gennova working on Omicron-specific Covid vaccine: Report
If given emergency-use approval, this would be the country's first mRNA Covid vaccine like the ones developed by Pfizer and Moderna
Covid-19 pill rollout stymied by shortages as Omicron variant rages
The problem is that production is not yet at full strength and that the pill considered to be far superior, Pfizer's, takes six to eight months to manufacture
South Korea gets first supply of Pfizer's antiviral Covid-19 pills
Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalisations and deaths
PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholder(s). PFIZER LTD. - 500680 - Shareholding for the Period Ended December 31, 2021
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here PFIZER LTD. - 500680 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 046451 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated January 11, 2022, issued by KFin Technologies Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2021. We request you to take the same on record.
COVID-19: South Korea approves Novavax vaccine, imports Pfizer pills
At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said.
Spanish PM Pedro Sanchez calls for debate on treating COVID-19 as endemic
Spanish PM Pedro Sanchez also announced that Spain is purchasing this month 344,000 pills of a COVID-19 antiviral drug developed by the US pharmaceutical giant Pfizer.